Emerging and re-emerging fungal threats in Africa. Dangarembizi, R., Wasserman, S., & Hoving, J. C. Parasite Immunology, John Wiley & Sons, Ltd, sep, 2022.
Emerging and re-emerging fungal threats in Africa [link]Paper  doi  abstract   bibtex   
The emergence of deadly fungal infections in Africa is primarily driven by a disproportionately high burden of human immunodeficiency virus (HIV) infections, lack of access to quality health care and the unavailability of effective antifungal drugs. Immunocompromised people in Africa are therefore at high risk of infection from opportunistic fungal pathogens such as Cryptococcus neoformans and Pneumocystis jirovecii, which are associated with high morbidity, mortality, and related socioeconomic impacts. Other emerging fungal threats include Emergomyces spp., Histoplasma spp., Blastomyces spp., and healthcare-associated multi-drug resistant Candida auris. Socioeconomic development and the Covid-19 pandemic may influence shifts in epidemiology of invasive fungal diseases on the continent. This review discusses the epidemiology, clinical manifestations, and current management strategies available for these emerging fungal diseases in Africa. We also discuss gaps in knowledge, policy, and research to inform future efforts at managing these fungal threats
@article{Dangarembizi2022,
abstract = {The emergence of deadly fungal infections in Africa is primarily driven by a disproportionately high burden of human immunodeficiency virus (HIV) infections, lack of access to quality health care and the unavailability of effective antifungal drugs. Immunocompromised people in Africa are therefore at high risk of infection from opportunistic fungal pathogens such as Cryptococcus neoformans and Pneumocystis jirovecii, which are associated with high morbidity, mortality, and related socioeconomic impacts. Other emerging fungal threats include Emergomyces spp., Histoplasma spp., Blastomyces spp., and healthcare-associated multi-drug resistant Candida auris. Socioeconomic development and the Covid-19 pandemic may influence shifts in epidemiology of invasive fungal diseases on the continent. This review discusses the epidemiology, clinical manifestations, and current management strategies available for these emerging fungal diseases in Africa. We also discuss gaps in knowledge, policy, and research to inform future efforts at managing these fungal threats},
author = {Dangarembizi, Rachael and Wasserman, Sean and Hoving, Jennifer Claire},
doi = {10.1111/PIM.12953},
file = {:C$\backslash$:/Users/01462563/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Dangarembizi, Wasserman, Hoving - 2022 - Emerging and re-emerging fungal threats in Africa.pdf:pdf},
issn = {1365-3024},
journal = {Parasite Immunology},
keywords = {dimorphic fungal pathogens,emerging fungi,fund{\_}ack,fungal pathogens,opportunistic fungal infections,review},
mendeley-tags = {fund{\_}ack,review},
month = {sep},
pages = {e12953},
pmid = {36175380},
publisher = {John Wiley {\&} Sons, Ltd},
title = {{Emerging and re-emerging fungal threats in Africa}},
url = {https://onlinelibrary.wiley.com/doi/full/10.1111/pim.12953 https://onlinelibrary.wiley.com/doi/abs/10.1111/pim.12953 https://onlinelibrary.wiley.com/doi/10.1111/pim.12953},
year = {2022}
}

Downloads: 0